Professor of Pharmacology and of Molecular Biophysics and Biochemistry
Co-Director Therapeutics/Chemotherapy Program
Individuals infected with HIV have a substantially higher risk of developing cancer compared with uninfected people of the same age. The Anderson laboratory is involved in developing new antiviral therapies to treat HIV infections. A major focus is HIV reverse transcriptase, a viral polymerase essential for HIV replication.<_o3a_p />
Henry Bronson Professor of Pharmacology
Chairman, Consortium for the Globalization of Chinese Medicine (CGCM)
The Cheng laboratory studies the action of antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.
Eugene Higgins Professor of Chemistry and Professor of Pharmacology
Jon was born and raised near Los Angeles and received his B.S. degree
at MIT and his Ph.D. degree from Harvard University. He was a postdoctoral
fellow at the University of California at Berkeley and subsequently joined the
faculty at the same institution. Prior to coming to Yale University, he was Professor in the Department of Chemistry at UC Berkeley and jointly
held a faculty position in the Department of Cellular and Molecular
Pharmacology at UC San Francisco. He has published more than 225...
David A. Sackler Professor of Pharmacology
Co-director, Cancer Biology Institute
Mark Lemmon, PhD was appointed the Co-Director of the Cancer Biology Institute and the David A. Sackler Professor of Pharmacology in 2015. Dr. Lemmon returns to Yale, where he completed his PhD in 1993, from the University of Pennsylvania’s Perelman School of Medicine. At UPenn, he was the George W. Raiziss Professor of Biochemistry and Biophysics as well as Chair of the department and an Investigator at the Abramson Family Cancer Research Institute. Dr. Lemmon’s research focuses on the...
Professor of Pharmacology
Director of Graduate Studies
Elias Lolis received his PhD in 1989 from MIT in Chemistry/Biochemistry studying the three-dimensional structure and mechanism of triosephosphate isomerase. He was a postdoctoral associate at the Laboratory of Medical Biochemistry at Rockefeller University studying the functional interaction between advanced glycation end products (AGEs) and the immune system. He joined the Yale faculty in 1991 as an Assistant Professor focusing on the structure, mechanism, and inhibition of chemokines,...
Assistant Professor of Pharmacology
Bryce received his Ph.D. from Queens University in Canada in 2002 where he studied signal transduction using yeast. From there he moved up the evolutionary scale to flies, still in the field of signal transduction and innate immunity, before settling on phage display and synthetic antibodies in the lab of Sachdev Sidhu in Toronto in 2010. Bryce set up a lab in Cold Spring Harbor Laboratory in 2013 and served as director of antibodies and phage display before accepting a position at the Yale...
Professor of Pharmacology
Professor Rudnick is a graduate of Antioch College, where he received a B.S. in Chemistry in 1968. He performed graduate studies in the enzymology of amino acid racemases in the laboratory of Robert H. Abeles in the Graduate Department of Biochemistry at Brandeis University, receiving a Ph.D. in Biochemistry in 1974. His graduate studies led to an understanding of the structure and mechanism of proline racemase that was confirmed by the crystal structure of a homologous protein in 2006. ...
Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology
Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Associate Director for Translational Research, Yale Cancer Center
Disease Aligned Research Team (DART) Leader, Thoracic Oncology Program, Yale Cancer Center